Silver Spring, MD, United States of America

Lalitha P V Nair

This inventor holds 2 USPTO granted patents. Top assignee: US Government as Represented by the Secretary of the Army. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lalitha P V Nair. Retrieved from https://idiyas.com/inventor/lalitha-p-v-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 57(Granted Patents)


Location History:

  • Silver Spring, MD (US) (2006)
  • New Delhi, IN (2006)

Company Filing History:


Years Active: 2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lalitha P. V. Nair: Inventor in Malaria Vaccine Research

Introduction

Lalitha P. V. Nair is an inventor associated with Silver Spring, Maryland, and the U.S. Government as represented by the Secretary of the Army. Her patent work concerns the production and potential applications of a recombinant malaria antigen. The available information credits her with 2 patents.

Latest Patents

Nair’s listed patents describe methods for expressing and purifying the ectodomain of recombinant 3D7 AMA-1. The methods aim to produce highly purified protein while preserving the folding and disulfide bridges of the native molecule.

The recombinant AMA-1 protein is described as useful as a diagnostic reagent and for antibody production. The patent descriptions also identify its potential use in a vaccine to prevent malaria, either alone or as part of a vaccine formulation.

Career Highlights

Nair’s patent activity reflects work at the intersection of biotechnology and infectious-disease research. Her listed inventions focus on producing a malaria-related protein in a form intended to retain properties important for research and potential medical applications.

Collaborations

The provided information names Lisa A. Ware and David E. Lanar as Nair’s coworkers. Their association with the same research area is reflected in the patent information supplied.

Conclusion

Lalitha P. V. Nair’s recorded patent work centers on recombinant AMA-1 production and its potential diagnostic, research, and vaccine applications against malaria.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…